These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5351142)

  • 1. [Cytogenetic studies in patients with thyroiditis and LATS and antibody-positive hyperthyroidism].
    Tolksdorf M; Schemmel K; Mühlenstedt D; Uthgenannt H; Müller W
    Schweiz Med Wochenschr; 1969 Jul; 99(30):1082-5. PubMed ID: 5351142
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoglobulin levels and long-acting thyroid stimulator (LATS) in hyperthyroidism. A preliminary study.
    Yamakido M; Yokoyama M; Noguchi S
    Hawaii Med J; 1969; 29(2):118-9. PubMed ID: 5361480
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
    [No Abstract]   [Full Text] [Related]  

  • 4. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
    Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
    J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 6. [LATS and thyroid antibody level in the blood in Basedow's disease].
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Orv Hetil; 1968 Aug; 109(33):1799-804. PubMed ID: 5714825
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological problems in thyroid diseases].
    Müller W
    Med Klin; 1969 Aug; 64(34):1487-92. PubMed ID: 4900624
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific and nonspecific responses in the bioassay of long-acting thyroid stimulator (LATS).
    Chopra IJ; Solomon DH; Limberg NP
    J Clin Endocrinol Metab; 1970 Oct; 31(4):382-90. PubMed ID: 5468701
    [No Abstract]   [Full Text] [Related]  

  • 9. [Parallel study of the thyrostimulating factor with prolonged action (LATS) and of circulating anti-thyroglobulin antibodies. Preliminary results].
    Liberti P; De Santis R; Grasso L; Martino E; Pinchera A; Baschieri L
    Folia Endocrinol; 1966 Dec; 19(6):659-66. PubMed ID: 6014021
    [No Abstract]   [Full Text] [Related]  

  • 10. Two sisters, one with Graves' disease and the second with thyroiditis and transient hyperthyroidism.
    Tong A; Farid NR; Stenszky V
    Acta Med Acad Sci Hung; 1982; 39(1-2):7-10. PubMed ID: 6897475
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relation between Basedow's disease and Hashimoto thyroiditis].
    Földes J; Takó J; Bános C; Gesztesi E; Juhász J
    Endokrinologie; 1971 Apr; 57(3):329-37. PubMed ID: 5108742
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
    Friis T
    Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-acting thyroid stimulator (LATS) and immunofluorescent studies in patients with pretibial myxoedema.
    From E; Diederichsen H; Heydenreich G; Nielsen OS
    Dan Med Bull; 1973 Dec; 20(6):188-91. PubMed ID: 4591336
    [No Abstract]   [Full Text] [Related]  

  • 14. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
    Busnardo B; Accordi F; Debiasi S
    Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-acting thyroid stimulator in euthyroid relatives of thyrotoxic patients.
    Wall JR; Good BF; Hetzel BS
    Lancet; 1969 Nov; 2(7629):1024-6. PubMed ID: 4187540
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on "cellular antibodies" against thyroid gland antigens in immunothyroiditis and hyperthyroidism].
    Helmke K; Böhm W; Federlin K
    Verh Dtsch Ges Inn Med; 1971; 77():1129-33. PubMed ID: 4949689
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-acting thyroid stimulator (LATS) and long acting thyroid stimulator protector (LATS-P) in untreated thyrotoxicosis.
    Hardisty CA; Hanford L; Humphries H; Munro DS
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):631-9. PubMed ID: 6895353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of long-acting thyroid stimulator to pretibial myxedema.
    Schermer DR; Roenigk HH; Schumacher OP; McKenzie JM
    Arch Dermatol; 1970 Jul; 102(1):62-7. PubMed ID: 4925011
    [No Abstract]   [Full Text] [Related]  

  • 19. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
    zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
    Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical studies on hyperthyroidism with special references to clinical-statistical surveys and studies on 131-I-triiodothyronine resin sponge uptake test and long-acting thyroid stimulator (LATS)].
    Hayashida M
    Sapporo Igaku Zasshi; 1966 Dec; 30(6):292-320. PubMed ID: 6010790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.